Apollon Financial, LLC Merck & Co., Inc. Transaction History
Apollon Financial, LLC
- $340 Billion
- Q3 2024
A detailed history of Apollon Financial, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Apollon Financial, LLC holds 2,055 shares of MRK stock, worth $202,581. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,055
Previous 1,665
23.42%
Holding current value
$202,581
Previous $206 Million
13.23%
% of portfolio
0.07%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,797Shares Held
1.92BCall Options Held
13.3MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA245MShares$24.1 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$11.6 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.15 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.83 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $250B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...